Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-000957-47Phase 3Completed
Phase 3 trial of bisoprolol and carvedilol in chronic heart failure (CHF) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Tolerance of target dose. Started Nov 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-000957-47.